Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q4EQ
|
|||
Former ID |
DIB015332
|
|||
Drug Name |
JNJ-38158471
|
|||
Synonyms |
VEGFR-2 inhibitors (angiogenesis disorder/cancer); VEGFR-2 inhibitors (angiogenesis disorder/cancer), Johnson & Johnson
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Angiogenesis disorder [ICD-11: BE2Z; ICD-10: I00-I99] | Investigative | [1] | |
Company |
Johnson & Johnson
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H17ClN6O3
|
|||
Canonical SMILES |
CCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC(=C2C=NOC)N)Cl
|
|||
InChI |
1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+
|
|||
InChIKey |
BJHCYTJNPVGSBZ-QPSGOUHRSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1813). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.